Impact of Age on Efficacy, Safety, and Long-Term Outcome of Chronic Myeloid Leukemia (CML) Patients Treated in First-Line with Nilotinib: An Analysis of the Gimema CML Working Party

被引：0

作者：

Gugliotta, Gabriele ^{[1
]}

Castagnetti, Fausto ^{[2
]}

Breccia, Massimo ^{[3
]}

D'Adda, Mariella ^{[4
]}

Stagno, Fabio ^{[5
]}

Levato, Luciano ^{[6
]}

Carella, Angelo Michele ^{[7
]}

Martino, Bruno ^{[8
]}

Tiribelli, Mario ^{[9
]}

Cambrin, Giovanna Rege ^{[10
]}

Gozzini, Antonella ^{[11
]}

Salvucci, Marzia ^{[12
]}

Cedrone, Michele ^{[13
]}

Trabacchi, Elena ^{[14
]}

Usala, Emilio ^{[15
]}

Scortechini, Anna Rita ^{[16
]}

Luciano, Luigia ^{[17
]}

Soverini, Simona ^{[18
]}

Alimena, Giuliana ^{[19
]}

Cavo, Michele ^{[20
]}

Martinelli, Giovanni ^{[21
]}

Pane, Fabrizio ^{[22
]}

Saglio, Giuseppe ^{[23
]}

Baccarani, Michele ^{[24
]}

Rosti, Gianantonio ^{[25
]}

机构：

[1] Univ Bologna, Inst Hematol L & A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[2] Univ Bologna, Inst Hematol L & A Seragnoli, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[3] Sapienza Univ, Div Hematol, Dept Cellular Biotechnol & Hematol, Rome, Italy

[4] ASST Spedali Civili Brescia, Div Hematol, Brescia, Italy

[5] Univ Catania, Chair Hematol, Catania, Italy

[6] AO Pugliese Ciaccio, Hematol Unit, Catanzaro, Italy

[7] IRCCS AOU San Martino IST, UO Hematol, Genoa, Italy

[8] AO Bianchi Melacrino Morelli, Hematol Unit, Reggio Di Calabria, Italy

[9] Azienda Osped Univ Udine, Div Hematol & BMT, Dept Expt & Clin Med Sci, Udine, Italy

[10] S Luigi Gonzaga Univ Hosp, Dept Clin & Biol Sci, Turin, Italy

[11] Careggi Univ Hosp, Hematol Unit, Florence, Italy

[12] S Maria Croci Hosp, Hematol Unit, Ravenna, Italy

[13] San Giovanni Addolorata Hosp, UOC Hematol, Rome, Italy

[14] Guglielmo da Saliceto Hosp, Hematol Unit, Piacenza, Italy

[15] A Businco Hosp, Hematol Unit, Cagliari, Italy

[16] Osped Riuniti Univ Hosp, Hematol Unit, Ancona, Italy

[17] Fed II Univ, Dept Biochem & Med Technol, Naples, Italy

[18] Univ Bologna, Inst Hematol L & A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[19] Sapienza Univ, Hematol Unit, Rome, Italy

[20] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[21] Univ Bologna, Inst Hematol L & A Seragnoli, Dept Expt Diagnost & Specialty Med, Bologna, Italy

[22] AOU Fed II Napoli, Hematol, Naples, Italy

[23] S Luigi Gonzaga Univ Hosp, Dept Hematol & Clin & Biol Sci, Turin, Italy

[24] Univ Bologna, Dept Hematol Oncol, Bologna, Italy

[25] Univ Bologna, Inst Hematol L & A Seragnoli, S Orsola Malpighi Hosp, Dept Expt Diagnost & Specialty Med, Bologna, Italy

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.3068.3068

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3068

引用

页数：5

共 50 条

[31] LONG-TERM OUTCOME TO FIRST-LINE IMATINIB ACCORDING TO 2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA: A GIMEMA CML WP ANALYSIS
Castagnetti, F.
Gugliotta, G.
Breccia, M.
Stagno, F.
Iurlo, A.
Albano, F.
Abruzzese, E.
Martino, B.
Levato, L.
Intermesoli, T.
Pregno, P.
Rossi, G.
Gherlinzoni, F.
Leoni, P.
Cavazzini, F.
Ferrero, D.
Usala, E.
Bocchia, M.
Tiribelli, M.
Montefusco, E.
Sica, S.
Venturi, C.
Soverini, S.
Cavo, M.
Alimena, G.
Martinelli, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2015, 100 : 128 - 128
[32] Long-Term Outcome to First-Line Imatinib according to 2013 European LeukemiaNet Response Criteria: a GIMEMA CML WP Analysis
Castagnetti, Fausto
Gugliotta, Cabriele
Breccia, Massimo
Stagno, Fabio Fabio
Lurlo, Alessandra
Albano, Francesco
Abruzzese, Elisabetta
Martino, Bruno
Levato, Luciano
Intermesoli, Tamara
Pregno, Patrizia
Rossi, Giuseppe
Gherlinzoni, Filippo
Leoni, Pietro
Cavazzini, Francesco
Ferrero, Dario
Usala, Emilio
Bocchia, Monica
Tiribelli, Mario
Montefusco, Enrico
Sica, Simona
Venturi, Claudia
Soverini, Simona
Cavo, Michele
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2015, 126 (23)
[33] Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, Philadelphia-positive chronic myeloid leukemia: The GIMEMA working party on CML
Palandri, Francesca
Iacobucci, Ilaria
Martinelli, Giovanni
Amabile, Marilina
Poerio, Angela
Testoni, Nicoletta
Soverini, Simona
Castagnetti, Fausto
De Vivo, Antonio
Breccia, Massimo
Specchia, Giorgina
Abruzzese, Elisabetta
Martino, Bruno
Cilloni, Daniela
Saglio, Giuseppe
Pane, Fabrizio
Liberati, Anna Marina
Rosti, Gianantonio
Baccarani, Michele
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 106 - 111
[34] Excellent Outcome and Good Tolerability of Long-Term Imatinib in Patients with Chronic Myeloid Leukemia (CML)
Claudiani, Simone
Gupta, Nikhita
Baik, Ji Soo
Deplano, Simona
Palanicawander, Renuka
Gerrard, Gareth
Reid, Alistair G.
Szydlo, Richard M.
Milojkovic, Dragana
Foroni, Letizia
Apperley, Jane F.
BLOOD, 2015, 126 (23)
[35] Deep Molecular Response to Nilotinib As First-Line Treatment of BCR-ABL plus CML in Early Chronic Phase: A Phase 3b Multicenter Study of the Gimema CML Working Party
Castagnetti, Fausto
Gugliotta, Gabriele
Breccia, Massimo
Martino, Bruno
Rossi, Giuseppe
Stagno, Fabio
Turri, Diamante
Tiribelli, Mario
Trabacchi, Elena
Isidori, Alessandro
Pierri, Ivana
Leonardi, Giovanna
Pregno, Patrizia
Carella, Angelo Michele
Bochicchio, Maria Teresa
Testoni, Nicoletta
Soverini, Simona
Specchia, Giorgina
Alimena, Giuliana
Cavo, Michele
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2014, 124 (21)
[36] Better molecular response (MR) to imatinib (IM) in early chronic phase (CP) versus late CP chronic myeloid leukemia (CML) patients (pts) in complete cytogenetic response (CCR): A comparison at 24 months of 2 clinical trials of the GIMEMA working party on CML on behalf of the GIMEMA working party on chronic myeloid leukemia (GIMEMA-CML).
Poerio, A
Amabile, M
Iacobucci, I
Soverini, S
Colarossi, S
Ottaviani, E
Terragna, C
Grafone, T
Luatti, S
Castagnetti, F
Pane, F
Saglio, G
Russo, D
Rosti, G
Baccarani, M
Martinelli, G
BLOOD, 2005, 106 (11) : 319A - 319A
[37] Molecular responses with nilotinib 800 mg daily as first-line treatment of chronic myeloid leukemia in chronic phase: Results of a phase II trial of the GIMEMA CML WP
Martinelli, G.
Castagnetti, F.
Poerio, A.
Breccia, M.
Palandri, F.
Alimena, G.
Pane, F.
Saglio, G.
Baccarani, M.
Rosti, G.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[38] Deletions of the Derivative Chromosome 9 Do Not Influence the Response and the Outcome of Chronic Myeloid Leukemia in Early Chronic Phase Treated With Imatinib Mesylate: GIMEMA CML Working Party Analysis
Castagnetti, Fausto
Testoni, Nicoletta
Luatti, Simona
Marzocchi, Giulia
Mancini, Marco
Kerim, Simonetta
Giugliano, Emilia
Albano, Francesco
Cuneo, Antonio
Abruzzese, Elisabetta
Martino, Bruno
Palandri, Francesca
Amabile, Marilina
Iacobucci, Ilaria
Alimena, Giuliana
Pane, Fabrizio
Martinelli, Giovanni
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2748 - 2754
[39] Chronic Myeloid Leukemia (CML) Patients with "Suboptimal" Response to Imatinib (IM) According to European LeukemiaNet Criteria Have a Poorer Outcome with Respect to "Optimal" Responders: A GIMEMA CML WORKING PARTY Analysis.
Castagnetti, Fausto
Gugliotta, Gabriele
Palandri, Francesca
Breccia, Massimo
Amabile, Marilina
Iacobucci, Ilaria
Testoni, Nicoletta
Marzocchi, Giulia
Luatti, Simona
Specchia, Giorgina
Intermesoli, Tamara
Abruzzese, Elisabetta
Capucci, Adele
Levato, Luciano
Radaelli, Franca
Martino, Bruno
Pregno, Patrizia
Montefusco, Enrico
Trentin, Livio
Alimena, Giuliana
Martinelli, Giovanni
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2009, 114 (22) : 864 - 864
[40] Restrospective Multicenter Study Evaluating Efficacy and Safety of Dasatinib and Nilotinib in Patients with Imatinib-Resistant or -intolerant Chronic Myeloid Leukemia in Chronic Phase: Korean CML Working Party
Lee, Jeong-Ok
Kim, Inho
Chung, Joo-Seop
Kim, Yeo-Kyeoung
Yhim, Ho-Young
Kim, Dae-Young
Do, Young-Rok
Seong, Chu-Myong
Nam, Seung-Hyun
Kim, Sung-Hyun
Lee, Jae-Hoon
Park, Jinny
Kim, Jin Seok
Min, Yoo-Hong
Sohn, Sang Kyun
Joo, Young Don
Bae, Sung-Hwa
Oh, Sukjoong
Zang, Dae Young
Lee, Hong Ghi
Yoon, Sung-Soo
Park, Seonyang
BLOOD, 2012, 120 (21)

← 1 2 3 4 5 →